- Home
- ITRG vs TIL Comparison
ITRG vs TIL Comparison
Compare ITRG & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRG
- TIL
- Stock Information
- Founded
- ITRG 1997
- TIL 2018
- Country
- ITRG Canada
- TIL United States
- Employees
- ITRG N/A
- TIL N/A
- Industry
- ITRG Precious Metals
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- ITRG Basic Materials
- TIL Health Care
- Exchange
- ITRG Nasdaq
- TIL Nasdaq
- Market Cap
- ITRG 277.2M
- TIL 230.1M
- IPO Year
- ITRG N/A
- TIL 2021
- Fundamental
- Price
- ITRG $1.54
- TIL $21.92
- Analyst Decision
- ITRG Strong Buy
- TIL Buy
- Analyst Count
- ITRG 1
- TIL 5
- Target Price
- ITRG $2.75
- TIL $119.00
- AVG Volume (30 Days)
- ITRG 1.2M
- TIL 345.1K
- Earning Date
- ITRG 08-13-2025
- TIL 08-12-2025
- Dividend Yield
- ITRG N/A
- TIL N/A
- EPS Growth
- ITRG N/A
- TIL N/A
- EPS
- ITRG N/A
- TIL N/A
- Revenue
- ITRG $87,375,000.00
- TIL N/A
- Revenue This Year
- ITRG $746.16
- TIL N/A
- Revenue Next Year
- ITRG N/A
- TIL N/A
- P/E Ratio
- ITRG N/A
- TIL N/A
- Revenue Growth
- ITRG N/A
- TIL N/A
- 52 Week Low
- ITRG $0.79
- TIL $9.62
- 52 Week High
- ITRG $1.95
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- ITRG 43.78
- TIL 40.10
- Support Level
- ITRG $1.41
- TIL $25.80
- Resistance Level
- ITRG $1.74
- TIL $23.30
- Average True Range (ATR)
- ITRG 0.09
- TIL 3.63
- MACD
- ITRG -0.02
- TIL -1.84
- Stochastic Oscillator
- ITRG 33.00
- TIL 1.91
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.